Effects of Dexmedetomidine on Minimum Alveolar Concentration of Sevoflurane for Blunting Sympathetic Response to Pneumoperitoneum: A Randomized Trial
Open Access
- 1 July 2025
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 19, 5899-5909
Abstract
Purpose: Laparoscopic procedures require abdominal inflation (pneumoperitoneum), which triggers strong stress responses that typically need high concentrations of sevoflurane to manage. Despite dexmedetomidine’s known anesthetic-sparing properties, its specific effects on sevoflurane minimum alveolar concentration for blunting sympathetic response (MACBAR) during pneumoperitoneum remain incompletely characterized. This study evaluates dexmedetomidine’s impact on sevoflurane requirements for blocking sympathetic responses during laparoscopic pneumoperitoneum. Patients and Methods: This prospective, randomized, double-blind, placebo-controlled trial enrolled 90 adults (aged 18– 45 years) classified as American Society of Anesthesiologists physical status I–II scheduled for elective laparoscopic cholecystectomy. Participants received either saline, low-dose dexmedetomidine (target 0.3 ng/mL), or high-dose dexmedetomidine (target 0.6 ng/mL). We determined sevoflurane MACBAR using Dixon’s up-and-down method, defined as the concentration preventing ≥ 20% increase in heart rate or mean arterial pressure following pneumoperitoneum. Secondary outcomes included hemodynamic responses, emergence time, adverse events, and plasma catecholamine levels. Results: Dexmedetomidine significantly reduced sevoflurane MACBAR compared to control (4.70% ± 0.18%; 95% confidence interval [CI], 4.61– 4.80): to 2.90% ± 0.19% (95% CI, 2.80– 3.00) in the low-dose group and to 1.90% ± 0.16% (95% CI, 1.82– 1.98) in the high-dose group (both p < 0.001). Patients receiving dexmedetomidine had significantly lower plasma epinephrine and norepinephrine levels following pneumoperitoneum compared to control (p < 0.001), with better hemodynamic stability. Emergence times and adverse event rates remained comparable between groups. Conclusion: Dexmedetomidine produces dose-dependent reductions in sevoflurane requirements for controlling sympathetic responses during pneumoperitoneum while maintaining hemodynamic stability, making it a valuable adjunct for anesthesia in laparoscopic surgery. Registration: The Chinese Clinical Trials Registry, ChiCTR2300071257.Keywords
This publication has 34 references indexed in Scilit:
- Effectiveness of dexmedetomidine on patient-centred outcomes in surgical patients: a systematic review and Bayesian meta-analysisBritish Journal of Anaesthesia, 2024
- Delirium in older patients given propofol or sevoflurane anaesthesia for major cancer surgery: a multicentre randomised trialBritish Journal of Anaesthesia, 2023
- Epileptiform EEG discharges during sevoflurane anesthesia in children: A meta-analysisClinical Neurophysiology, 2022
- Effect of dexmedetomidine on hemodynamic responses to tracheal intubation: A meta-analysis with meta-regression and trial sequential analysis.Journal of Clinical Anesthesia, 2021
- Reporting of Multi-Arm Parallel-Group Randomized TrialsJAMA, 2019
- Clinical Pharmacokinetics and Pharmacodynamics of DexmedetomidineClinical Pharmacokinetics, 2017
- The effect of remifentanil on the minimum alveolar concentration of isoflurane in childrenJournal of Clinical Anesthesia, 2015
- Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysisInternational Journal of Surgery, 2015
- Intranasal dexmedetomidine premedication reduces the minimum alveolar concentration of sevoflurane for tracheal intubation in children: a randomized trialJournal of Clinical Anesthesia, 2014
- Effects of propofol on the minimum alveolar concentration of sevoflurane for immobility at skin incision in adult patientsJournal of Clinical Anesthesia, 2010